SCHEMBL23309510

SCHEMBL23309510

Cc1ccc(NC(=O)c2cc(F)nc(F)c2)cc1Cl

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 9/20 0.57
▸ RAB9A P51151 8/20 0.57
▸ SMN1; SMN2 Q16637 4/20 0.57
▸ MAPT P10636 2/20 0.57
▸ TP53 P04637 1/20 0.57
▸ MEN1 O00255 4/20 0.54
▸ KMT2A Q03164 4/20 0.54
▸ CASP3 P42574 2/20 0.54
▸ SENP7 Q9BQF6 2/20 0.54
▸ SENP6 Q9GZR1 1/20 0.54
▸ ALDH1A1 P00352 1/20 0.53
▸ LMNA P02545 1/20 0.53
▸ HSD17B10 Q99714 1/20 0.53
▸ POLB P06746 2/20 0.51
▸ L3MBTL1 Q9Y468 2/20 0.51
▸ CYP1A2 P05177 1/20 0.51
▸ CYP3A4 P08684 1/20 0.51
▸ CYP2C9 P11712 1/20 0.51
▸ CYP2C19 P33261 1/20 0.51
▸ KCNQ3 O43525 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309565 0.87 NPC1 (0.66) NPC1RAB9ASMN1; SMN2MAPTMEN1
SCHEMBL17803491 0.85 NPC1 (0.68) NPC1RAB9ASMN1; SMN2MAPTMEN1
SCHEMBL12443604 0.82 NPC1 (0.73) NPC1RAB9ASMN1; SMN2MAPTTP53
SCHEMBL23309539 0.81 NPC1 (0.52) NPC1RAB9ASMN1; SMN2MAPTTP53
SCHEMBL23309664 0.80 RAB9A (0.62) NPC1RAB9ASMN1; SMN2MAPTTP53
SCHEMBL23309551 0.80 MAPK1 (0.58) NPC1RAB9ASMN1; SMN2MAPTTP53
SCHEMBL7748140 0.79 NPC1 (0.73) NPC1RAB9ASMN1; SMN2MAPTTP53
SCHEMBL15177192 0.79 NPC1 (0.67) NPC1RAB9ASMN1; SMN2MAPTTP53
SCHEMBL23309572 0.78 NPC1 (0.47) NPC1RAB9ASMN1; SMN2MAPTMEN1
SCHEMBL23309573 0.77 MEN1 (0.64) NPC1RAB9ASMN1; SMN2TP53MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL NPC1 412/4885RAB9A 286/4885SMN1; SMN2 3893/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback